Evaluation of Antiplatelet Therapy in Lower Limb Endovascular Treatment.

Trial Profile

Evaluation of Antiplatelet Therapy in Lower Limb Endovascular Treatment.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 May 2017

At a glance

  • Drugs Cilostazol (Primary) ; Aspirin
  • Indications Embolism and thrombosis; Peripheral arterial disorders; Restenosis
  • Focus Therapeutic Use
  • Acronyms STOP-IC
  • Most Recent Events

    • 19 Jun 2009 New source identified and integrated (University Hospital Medical Information Network - Japan UMIN000002091).
    • 16 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top